Abstract:OBJECTIVE:To investigate whether rapamycin (RPM) can reduce the neointima formation in the autologous vein graft, thus to provide support for its clinical application.METHODS:Twenty-four male rabbits were made external jugular vein-to-common carotid artery models and then were divided into 4 equal groups at random: blank-control group; F-127 control group receiving local application of 0.5 ml 20% F-127 around the vein graft; low-dose RPM group, receiving local application of 0.5 ml 20% F-127 containing RPM of 50 microg/cm(2); and high dose RPM group, receiving local application of 0.5 ml 20% F-127 containing RPM of 100 microg/cm2. The rabbits were killed 3 weeks later and the samples of vein graft bridge were taken to undergo light microscopy. The ratio of intima to media thickness and restenosis rate (ratio of lumina to lumina plus intima area) were measured. Immunohistochemistry was used to detect the proliferating cell nuclear antigen (PCNA) positive cells so as to indicate the degree of cell proliferation. The apoptosis cells were detected by TUNEL to indicate the degree of cell apoptosis.RESULTS:The intima thickness levels of the low- and high-dose RPM groups were 29 microm +/- 10 microm and 16 microm +/- 8 microm respectively, both significantly lower than those of the blank-control group and F-127 control group (90 microm +/- 11 microm and 85 microm +/- 11 microm respectively, all P < 0.05). The restenosis rate (lumina area/total area ratio) of the low- and high-dose RPM groups were 0.80 +/- 0.36 and 0.91 +/- 0.13 respectively, both significantly higher than those of the blank-control group and F-127 control group (0.58 +/- 0.11 and 0.65 +/- 0.47 respectively, all P < 0.05). The cell proliferation indicis of vascular smooth muscle cells (VSMCs) of the low- and high-dose RPM groups were 20% +/- 9% and 14% +/- 6% respectively, both significantly lower than those of the blank-control group and F-127 control group (31% +/- 7% and 35% +/- 6%, all P < 0.05). The cell apoptosis indicis of the low- and high-dose RPM groups were 33% +/- 7% and 36% +/- 7% respectively, both significantly lower than those of the blank-control group and F-127 control group (16% +/- 6% and 18.% +/- 8% respectively, all P < 0.05).CONCLUSION:Local delivery of slow-releasing RPM by F-127 effectively inhibits the neointima hyperplasia in vein graft by a mechanism of reducing the VSMC proliferation and inducing cell apoptosis.

Gene Transfer of Calcitonin Gene-Related Peptide Inhibits Macrophages and Inflammatory Mediators in Vein Graft Disease

Gene Transfer of A Broad Spectrum Cc-Chemokine Inhibitor Reduces Vein Graft Atherosclerosis in Apolipoprotein E-Knockout Mice

Local Gene Transfer of Tissue Inhibitor of Metalloproteinase-2 Influences Vein Graft Remodeling in a Mouse Model

MicroRNA-221 sponge therapy attenuates neointimal hyperplasia and improves blood flows in vein grafts

P38 MAPK Inhibitor, CBS3830 Limits Vascular Remodelling in Arterialised Vein Grafts.

Intramuscular gene transfer of CGRP inhibits neointimal hyperplasia after balloon injury in the rat abdominal aorta.

Overexpression of CGRP receptor attenuates tendon graft degeneration in anterior cruciate ligament reconstruction

Adenovirus-Mediated Gene Transfer Of Microrna-21 Sponge Inhibits Neointimal Hyperplasia In Rat Vein Grafts

Effect of Early Inflammation on the Efficacy of Gene Transfer to Vein Graft

Expression of calcitonin gene-related peptide in human umbilical veinendothelial cells transfected with retroviral vectors in vitro

Early Growth Response Gene-1 Decoy Oligonucleotides Inhibit Vascular Smooth Muscle Cell Proliferation and Neointimal Hyperplasia of Autogenous Vein Graft in Rabbits.

Preventing Intimal Thickening of Vein Grafts in Vein Artery Bypass Using STAT-3 Sirna

Α-Ketoglutaric Acid Reprograms Macrophages by Altering Energy Metabolism to Promote the Regeneration of Small-Diameter Vascular Grafts.

Inhibitory Effect of TLR4 Gene Silencing on Intimal Hyperplasia of Vein Grafting

Anti-inflammatory and anti-proliferative effects of CBS3830 in arterialized vein grafts in rats.

[Pretreatment of Isolated Vein with Rapamycin Nanoparticles Inhibits Vein Graft Stenosis in Rabbits].

Local Applied Slow-Releasing Rapamycin Inhibits Neointima Hyperplasia in Vein Graft

Local Tansfection of Antisense Transforming Growth Factor-Β1 Carried by Nanoparticles Inhibits Intimal Hyperplasia in Autogenous Vein Grafts in Rats

MicroRNA-146a sponge therapy suppresses neointimal formation in rat vein grafts.

A Macro-porosity, Nonrestrictive External Stent Inhibits Rabbit Vein Graft Neointima Thickening

Empirical Study of Transfecting Early Growth Response Gene‐1 DNA Enzyme to Prevent Intimal Hyperlasia of Autogenous Vein Graft in Rats